Articles tagged with Gastroenterology
Researchers identified predictive molecular biomarkers for non-response to anti-TNF and anti-integrin therapies in UC. Biomarkers in innate and adaptive immune systems, as well as proteolytic degradation, were found to be predictive of therapy non-response.
Researchers found that most IBS patients have visible bacterial biofilms in their gut under endoscopic examination, which can impair gut function. Biofilms can also occur in ulcerative colitis patients, and irrigation therapy shows promise in alleviating symptoms.
A new study found that coeliac disease cases in school-age children have doubled in the past 25 years due to mass screening. The prevalence of coeliac disease was found to be 1.6%, significantly higher than previously thought, highlighting the importance of early diagnosis and treatment.
A recent study has found that children born to mothers who took fish oil during pregnancy have faster problem-solving skills and better attention focus at age 10. The study, funded by the European Union, also showed that maternal fish oil supplementation had a lasting impact on brain function in school-aged children.
The American Gastroenterological Association (AGA) recommends early introduction of biologics for patients with moderate-to-severe luminal and fistulizing Crohn's disease. Biologics are the most effective treatment option, which should be used early rather than delaying their use until other treatments fail.
A new artificial intelligence tool can analyze patients' stool images to help diagnose chronic gastrointestinal issues such as IBD and IBS. The Smart Toilet technology provides a more accurate and timely diagnosis by collecting long-term data on stool form and presence of blood.
A consensus definition clarifies the characteristics of postbiotics, a category of non-living microorganisms with potential health benefits. The definition distinguishes postbiotics from probiotics and outlines their composition and application.
Researchers have developed a novel strategy to treat, prevent, and possibly reverse liver damages by exploiting small extracellular vesicles derived from interferon-γ pre-conditioned MSCs. The approach has shown promising results in reducing inflammation and fibrosis in a mouse model of cirrhosis.
The American Gastroenterological Association has released new clinical guidelines recommending the use of intragastric balloons for patients with obesity who have not been able to lose weight with traditional strategies. The treatment is most successful when combined with lifestyle modifications and pharmacological agents, and can be u...
Research summarizes COVID-19 gastrointestinal symptoms in patients, detecting SARS-CoV-2 RNA and virus particles in intestinal samples. Animal models suggest high susceptibility of intestines to SARS-CoV-2 infection, with potential faecal-oral transmission risks.
The International Journal of Gastroenterology and Hepatology Diseases is a new subscription-based journal publishing articles on global significance gastrointestinal and liver diseases. It aims to publish experimental and theoretical results in detail, covering advancements in management and diagnosis of diseases.
Researchers at Brigham and Women's Hospital have developed a bilayered capsule that can deliver bile acids to the colon, reducing cramping and providing constipation relief. The new treatment has shown promise in preclinical studies and is expected to begin clinical trials within 18 months.
Researchers have identified specific geographic areas in the US where women diagnosed with early-onset colorectal cancer before age 50 face higher mortality rates. The study found nearly one quarter of adults in hot spot counties reported no physical activity, and fertility may contribute to this variation.
A new study has shown that a minimally-invasive ablation procedure can rejuvenate the lining of the duodenum, leading to significant improvements in blood glucose control and weight loss. In a pilot study, 75% of patients with type 2 diabetes who underwent the procedure were able to discontinue insulin therapy within six months.
A new study found that asthma and food hypersensitivity in children are associated with an increased risk of developing irritable bowel syndrome (IBS) during adolescence. Children with IBS were nearly twice as likely to have had asthma, and almost half reported food hypersensitivity.
A new study analyzed 1,435,350 patients with concurrent diabetes and obesity over a 20-year period. Bariatric surgery was found to significantly reduce the prevalence of pancreatic cancer (0.32% vs 0.19%, p<0.05) in obese diabetic patients. The majority of patients who underwent surgery were female.
The AGA Fecal Microbiota Transplantation National Registry reported that FMT led to a cure of C. difficile infection in 90% of patients across 20 North American FMT practice sites, with few serious side effects. The study included 259 patients enrolled between December 2017 and September 2019.
The American Gastroenterological Association (AGA) recommends bidirectional endoscopy for asymptomatic patients with iron deficiency anemia to detect underlying causes such as gastrointestinal malignancy, peptic ulcer disease, and inflammatory bowel disease. Non-invasive testing, including Helicobacter pylori and celiac disease testing...
A group of international scientists has developed a new definition for synbiotics, outlining a mixture of live microorganisms and selectively utilized substrates that confer a health benefit on the host. The definition aims to clarify scientific ambiguity and provide a foundation for science-based claims about synbiotic health benefits.
Researchers found patients in multidisciplinary clinics experienced greater symptom relief and improved wellbeing compared to standard care. Multidisciplinary clinics showed a 84% improvement rate, while standard care had a 57% improvement rate.
A new study from Aarhus University and Aarhus University Hospital found that three hours of weekly strength training combined with protein supplements can break the vicious circle of muscle loss in patients with cirrhosis. This leads to improved muscle strength, size, functional capacity, and quality of life.
The American Gastroenterological Association recommends against using probiotics to treat most digestive diseases due to a lack of strong evidence supporting their efficacy. However, certain probiotic formulations may benefit patients in specific situations, such as preventing Clostridioides difficile infection or managing pouchitis.
A study of over 73,000 people in 33 countries found that four out of ten adults worldwide have functional gastrointestinal disorders. The disorders, which include symptoms like heartburn and irritable bowel syndrome, were more prevalent in women and associated with lower quality of life.
Recent studies on NAFLD have made significant progress in understanding the risk factors, diagnosis, and treatment of the condition. The latest research emphasizes the importance of gut microbiota modulation to improve severity, as well as the role of hepatic inflammatory pathways in driving comorbidities.
A new study analyzed data from an international registry of 528 IBD patients with COVID-19, finding that increasing age, comorbidities, and corticosteroids are associated with severe illness. The study also suggests that steroid-sparing treatments may be crucial for maintaining remission in IBD patients during the pandemic.
Researchers at McMaster University have established a strong association between inflammatory bowel disease (IBD) and celiac disease. The study found a nine-fold increased risk of IBD in patients with a previous diagnosis of celiac disease, highlighting the importance of proper screening and treatment for both conditions.
A new special issue of Clinical Gastroenterology and Hepatology highlights major advances in IBD treatment. The issue provides comprehensive updates on algorithmic treatments to reduce morbidity and emphasizes the importance of treating beyond symptom relief.
The American Gastroenterological Association has published new evidence-based recommendations on the GI and liver manifestations of COVID-19. Key findings include a lower prevalence of GI symptoms in outpatients (4.0%), but also highlight atypical presentations, such as diarrhea preceding other symptoms by days.
The American Gastroenterological Association (AGA) has released new guidelines for the management of eosinophilic esophagitis (EoE), a chronic inflammatory disease of the esophagus triggered by allergens. Topical steroids are recommended as a first-line treatment, while proton pump inhibition, diet therapy, and esophageal dilation are ...
The American Gastroenterological Association has released official guidance for patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic. According to the AGA, patients with IBD should continue their medication, including scheduled infusions, and stop certain medications if they develop COVID-19 symptoms.
The American Gastroenterological Association has issued new COVID-19 guidelines recommending enhanced personal protective equipment (PPE) for gastrointestinal procedures, including the use of N95 masks and double gloves. The guidelines aim to minimize the risk of infection transmission among healthcare workers and patients.
A precision medicine approach is necessary to determine which patients with diverticulitis need a colonoscopy. The editorial highlights 'sign posts' that support individualized decision-making and recommends their use. This approach uses healthcare resources wisely and provides better patient care.
Researchers identified predictive models for Crohn's disease, including a serum biomarker model with 76% accuracy, and explored the link between metal exposure in early life and IBD risk. Achieving deep remission early on was also associated with a significant decrease in long-term complications.
A study in The American Journal of Gastroenterology reveals that nearly half of COVID-19 patients in China presented with digestive symptoms like diarrhea and anorexia, which prolonged hospital stays and reduced recovery rates.
Key information for gastroenterologists and patients with chronic digestive conditions about COVID-19 includes prioritizing patient safety and maintaining medication regimens. Laboratory findings in COVID-19 patients also include liver function test abnormalities, emphasizing the importance of monitoring.
A study published in JPGN found that proton pump inhibitors (PPIs) may increase the risk of fractures in pediatric patients. The analysis showed a significantly higher fracture rate in children exposed to PPIs, with a 20% higher probability of fracture compared to non-exposed children.
Research published in Gastroenterology highlights GI symptoms and potential fecal transmission in coronavirus patients. Key findings include viral RNA detectable in stool and the virus shedding into the digestive system, raising concerns about fecal-oral transmission.
Experts provide a timeline for patients to be rechecked for colorectal cancer based on their initial colonoscopy and recommend the safest techniques to completely remove polyps. Screening is recommended to begin at age 50, with follow-up colonoscopies every 3-10 years depending on polyp size and removal.
The new clinical guideline provides recommendations for immunomodulators, biologics, and small molecules to bring on and maintain remission in adult outpatients with moderate to severe UC. It also suggests early use of biologics with or without immunomodulator therapy.
Gastric intestinal metaplasia is a marker associated with increased risk of gastric cancer, prompting the need for standardized clinical practice. The new AGA guideline provides evidence-based recommendations for testing H. pylori eradication and surveillance strategies.
A new study published in the UEG Journal found that young patients with inflammatory bowel disease (IBD) are at a higher risk of developing severe viral infections. Clinically active IBD and immunomodulators used to treat the condition are identified as main drivers of infection, with thiopurines increasing the risk by six times.
A new study found that 18 drug categories extensively impact the taxonomic structure and metabolic potential of the gut microbiome. Researchers identified eight categories increasing antimicrobial resistance mechanisms. The changes could increase risk of intestinal infections, obesity, and other conditions linked to the gut microbiome.
A major study across 195 countries found that global death rates for pancreatic cancer and incidence rates for colorectal cancer increased by 10% between 1990 and 2017. The study also reported significant increases in cases of inflammatory bowel disease (IBD) and a rise in obesity-related risk factors for pancreatic cancer.
A new study confirms FMT is effective in treating IBS with high response rates and symptom improvements, but selecting the right donor is crucial for success. The study used a 'super-donor' to produce high rates of clinical response and marked symptom improvements in patients with IBS.
A study found that plant-based diets and Mediterranean diets are associated with high levels of friendly gut bacteria, aiding nutrient production and SCFA energy for cells lining the colon. Plant protein helps biosynthesis of vitamins and amino acids.
A new national poll suggests that older adults are hesitant to try virtual health visits due to concerns about technology and quality of care. Despite this, many (64%) would be interested in telehealth options if they became unexpectedly ill while traveling or needed follow-up on previous care.
A large registry-based study found that current scoring systems have moderate reliability in predicting severe liver disease risk. The study identified individuals with normal scores as being at a very low risk of developing severe liver disease, highlighting the need for new methods to detect those at higher risk.
Researchers at MIT have developed a new gel-like material that can create a stable cushion for more than an hour, reducing the risk of tearing the colon lining during polyp removal. This innovation could greatly improve the safety and effectiveness of colonoscopies.
A large, multi-year randomized trial found no evidence to support claims that PPIs cause serious health issues such as pneumonia, chronic kidney disease, diabetes, and dementia. The study suggests that limiting prescriptions of PPI therapy is not appropriate due to the benefits outweighing the risks.
A study published at the 52nd Annual Meeting of ESPGHAN found that high fiber intake during pregnancy is linked to a decreased risk of childhood coeliac disease. The study, which assessed over 88,000 children, showed that mothers with higher fiber intake had lower rates of coeliac disease in their offspring.
A recent study published in Journal of Gastroenterology and Hepatology found that removing the gallbladder can reduce the risk of stroke by 40% in patients with gallstones. The study analyzed data from 310,712 patients and observed a lower risk regardless of age or medical conditions.
Research found that button batteries can cause gastric wall perforation and erosive injuries in 60% of cases, regardless of symptom presence or passage time. Clinicians should consider removing batteries promptly to avoid repeated ER visits and imaging.
A study published in Gastroenterology suggests that patients with IBS who have multiple intestinal and brain abnormalities experience more severe symptoms, making combination therapy a potential solution to improve treatment outcomes
A recent commentary suggests that treatment guidelines recommended by medical specialist organizations are more likely to lead to overdiagnosis, overtreatment, and increased healthcare costs. The authors argue that specialty bias and fee-for-service compensation models contribute to this issue.
Researchers have identified new pathways controlling inflammation in the gut and explored diet-based interventions to prevent C. difficile infections. Prebiotics may also help mitigate gastrointestinal toxicity from radiation treatment.
The American Gastroenterological Association has launched the AGA FORWARD Program to promote diversity in gastroenterology. The program's inaugural class of 10 Scholars includes underrepresented minority leaders who will receive mentorship and training to strengthen their research and management skills.
Studies presented at the Crohn's & Colitis Congress highlight advancements in treatments for patients with inflammatory bowel disease (IBD), including JAK inhibitors and biologics targeting immune cell trafficking. These therapies show promise for effective and safe oral therapeutic options for moderate to severe ulcerative colitis.
Studies highlight the importance of treating IBD as a whole person, including reproductive and mental health aspects. Patient-provider communication is key to improving health outcomes and addressing emotional exhaustion associated with IBD.
The American Gastroenterological Association has announced the 2019 recipients of the annual recognition awards, honoring outstanding contributions to the field of gastroenterology. The award winners include John I. Allen, MD, MBA, AGAF; Harry B. Greenberg, MD; and Timothy C. Wang, MD, AGAF.
A national study is comparing three FDA-approved treatments for fecal incontinence: biofeedback therapy, inert injectable compounds, and pacemaker stimulation. The five-year study aims to determine which treatment is most effective and safe for patients with moderate to severe fecal incontinence.